Drawing for KIRIN

USPTO serial 79269305

KIRIN

Reviewed by CopyMark Law Group

Reg. 6350506Status 700Renewal
Filing date
Status date
Registration date
May 18, 2021
Examiner
NIEMANN, SHELBY LYNN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with KIRIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen Lim

Karen Lim Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St., 17th Fl.New York, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Milk ferments for pharmaceutical purposes; collyrium; nasal spray preparations for medical purposes; nasal spray preparations; vaginal pharmaceutical preparations for treating fungal infections; pharmaceutical antitussive-cold preparations; preparations for destroying vermin; fungicides; herbicides; pharmaceutical preparations for the treatment of gastrointestinal diseases, cancer, bacterial skin infections, vitamin deficiencies, intestinal bacteria, influenza, colds, physical disorders, fatigue, anemia, leukopenia, hyperphosphatemia, hyperparathyroidism, leukemia, influenza, HIV, myelodysplastic syndrome, hepatitis virus infection and autoimmune hepatitis; pharmaceutical preparations for mobilization of peripheral blood progenitor cells; pharmaceutical preparations for conditioning treatment prior to hematopoietic stem cell transplantation; medical and veterinary preparations, namely, diagnostic, bacterial, and bacteriological preparations for medical or veterinary purposes; vitamin preparations, not for pain relief or cosmetic purposes; vitamin substances in the nature of vitamin supplements, not for pain relief or cosmetic purposes; nutritional additives for medical purposes, not for pain relief or cosmetic purposes; medicinal tonics and substitutes therefor, namely, dietary supplements for humans and animals, not for pain relief or cosmetic purposes; calcium pharmaceutical preparations in the nature of calcium supplements, not for pain relief or cosmetic purposes; reagent paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; capsules sold empty for pharmaceuticals; mothproofing paper; lacteal flour for babies; dietary and nutritional supplements in tablet, chewable, powder, capsule, liquid or gel form, not for pain relief or cosmetic purposes; lactic acid bacteria-based food supplements in gel, tablet, chewable, powder, capsule or liquid form, not for pain relief or cosmetic purposes; dietary and nutritional supplements, not for pain relief or cosmetic purposes; dietetic pharmaceuticals, namely, dietetic foods and beverages adapted for medical or veterinary use; dietetic food adapted for medical purposes, namely, food for chewing and swallowing disorders; food thickener for dysphagia for medical purposes, namely, food additives in the nature of glucose and lecithin for medical purposes for assistance with swallowing; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies, namely, dietary supplement beverages for aiding sleep and promoting digestion for babies; food for babies; nutritional supplements for animal foodstuffs, not for pain relief or cosmetic purposes; dietary supplements for animals, not for pain relief or cosmetic purposes; semen for artificial insemination; cultures of microorganisms for medical or veterinary useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 18, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 23, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 24, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 1, 2021XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 1, 2021XXCRGENERIC MADRID TRANSACTION CREATED—
Aug 18, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 18, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 27, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 10, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 10, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 2, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 2, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2021GPNXNOTIFICATION PROCESSED BY IB—
Feb 10, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 10, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 10, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 21, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 11, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 10, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 10, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 11, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 11, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 11, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 18, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 18, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 11, 2020ALIEASSIGNED TO LIE—
May 6, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 6, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 6, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 6, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 6, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 6, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 6, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 22, 2019RFNTREFUSAL PROCESSED BY IB—
Nov 6, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 6, 2019RFRRREFUSAL PROCESSED BY MPU—
Oct 22, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 22, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 21, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2019DOCKASSIGNED TO EXAMINER—
Oct 16, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 10, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance